The Benefits and Risks of the Class of Selective Serotonin Reuptake Inhibitors (SSRIs), (90 Minutes broadcast)
03.04.2002
If you would like more information, please contact Connie M. Proulx, Director of Marketing, at 303.244.1919 or
proulx@wtotrial.com.